Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2016	Jan. 31, 2015	Jan. 31, 2014
OPERATING ACTIVITIES:
Net income	$ 8,561	$ 31,796	$ 42,902
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	13,951	14,761	12,449
Amortization of intangible assets	3,658	2,608	1,746
Goodwill impairment loss	7,413	0	0
Change in fair value of acquisition-related contingent consideration	(721)	714	540
Income from equity investment	(83)	(28)	(116)
Deferred income taxes	(3,021)	(958)	623
Share-based compensation expense	2,311	4,213	4,198
Change in operating assets and liabilities	9,847	7,973	(10,449)
Other operating activities, net	2,092	(996)	943
Net cash provided by operating activities	44,008	60,083	52,836
INVESTING ACTIVITIES:
Capital expenditures	(13,046)	(17,041)	(30,701)
Proceeds (payments) related to business acquisitions	351	(12,472)	0
Proceeds from sale of short-term investments	250	500	0
Purchases of investments	(250)	(750)	(250)
Proceeds from sale of assets	2,124	0	0
Other investing activities, net	(503)	(223)	(664)
Net cash used in investing activities	(11,074)	(29,986)	(31,615)
FINANCING ACTIVITIES:
Dividends paid	(19,426)	(18,519)	(17,465)
Payments for common shares repurchased	(29,338)	0	0
Additional borrowings	0	2,127	0
Payment of revolving line of credit and acquisition-related debt	0	(14,116)	0
Payment of acquisition-related contingent liabilities	(814)	(533)	(353)
Debt issuance costs paid	(548)	0	0
Restricted stock units vested and issued	(458)	0	0
Employee stock option exercises net of tax benefit	(85)	702	464
Other financing activities, net	(15)	(326)	0
Net cash used in financing activities	(50,684)	(30,665)	(17,354)
Effect of exchange rate changes on cash	(417)	(470)	(233)
Net (decrease) increase in cash and cash equivalents	(18,167)	(1,038)	3,634
Cash and cash equivalents at beginning of year	51,949	52,987	49,353
Cash and cash equivalents at end of year	$ 33,782	$ 51,949	$ 52,987